Evidence map›Paper›PMID 41479509›Full record

ArticleWorld journal of hepatology2025

Performance of artificial intelligence in predicting hepatocellular carcinoma recurrence after thermal ablation: A systematic review.

Alessandro Posa, Marcello Lippi, Pierluigi Barbieri, Edoardo Vincenzo Andreani, Roberto Iezzi

Abstract read
In one paragraph

Article in World journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alessandro PosaDepartment of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome 00168, Lazio, Italy. alessandro.posa@policlinicogemelli.it.
Marcello LippiDepartment of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome 00168, Lazio, Italy.
Pierluigi BarbieriDepartment of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome 00168, Lazio, Italy.
Edoardo Vincenzo AndreaniDepartment of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome 00168, Lazio, Italy.
Roberto IezziDepartment of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome 00168, Lazio, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecurrence prediction of hepatocellular carcinoma (HCC) after thermal ablation represents a challenge that can impact patients' quality of life. Artificial intelligence (AI)-based radiomics models applied to various imaging modalities can improve recurrence prediction, therefore guiding therapeutic decisions.

aimTo evaluate the effectiveness of AI-driven predictive models in predicting HCC recurrence.

methodsA systematic literature search in PubMed and Scopus was performed, and a total of ten studies were included in this systematic review. All studies included response prediction evaluation with AI models for patients who underwent thermal ablation for HCC. Deep learning and machine learning algorithms were utilized to evaluate the predictive performance and accuracy through metrics such as the area under the curve and concordance index.

resultsThe developed models demonstrated high accuracy in predicting local progression and recurrence, allowing a solid risk stratification. In particular, the integration of imaging data and clinical-laboratory variables optimized treatment selection, highlighting the superior ability of imaging models to predict therapeutic outcomes compared to clinical parameters alone. Furthermore, radiomic analysis of follow-up imaging enabled highly accurate detection of ablation site recurrence.

conclusionAI-driven predictive models based on multimodal radiomic analyses integrated with clinical data represent promising tools for predicting tumor recurrence after thermal ablation in HCC patients.

Indexed as

Artificial intelligenceHepatocellular carcinomaPredictionThermal ablationTumor recurrence

Identifiers

PMID41479509
PMCPMC12754441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.